Ford Alexander

Avg. Two Year Performance

No purchase track record

(13%) Avg. Sale Return

(6%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	8%	30%	37%	10%	(13%)
Sale Success Rate	2 of 4	2 of 4	2 of 4	3 of 4	1 of 4

Myriad Genetics Inc.

Drugs » Diagnostic Substances

Chief Operating Officer:

Holdings: 169.04K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--